| Product Code: ETC7373416 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Grenada saw a significant increase in large molecule drug substance CDMO import shipments, with top exporters including India, Saint Lucia, Barbados, Ireland, and Trinidad and Tobago. The market concentration, as measured by HHI, shifted from high to moderate in 2024, indicating a more balanced distribution among exporting countries. The compound annual growth rate (CAGR) for the period 2020-2024 stood at a healthy 4.45%, with an impressive growth rate of 29.86% from 2023 to 2024. These trends suggest a dynamic and evolving market landscape for large molecule drug substances in Grenada.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Large Molecule Drug Substance CDMO Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Grenada Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Grenada Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for large molecule drugs due to their effectiveness in treating complex diseases. |
4.2.2 Growing trend of outsourcing drug substance manufacturing to CDMOs for cost-efficiency and expertise. |
4.2.3 Advancements in biotechnology leading to the development of more large molecule drugs. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and quality standards in the pharmaceutical industry. |
4.3.2 Competition from established CDMOs with strong track records and client relationships. |
5 Grenada Large Molecule Drug Substance CDMO Market Trends |
6 Grenada Large Molecule Drug Substance CDMO Market, By Types |
6.1 Grenada Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Grenada Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Grenada Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Grenada Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Grenada Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Grenada Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Grenada Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Capacity utilization rates at Grenada CDMO facilities. |
8.2 Number of successful technology transfers and new project onboarding. |
8.3 Percentage of repeat business and client satisfaction levels. |
8.4 Innovation and investment in new technologies and capabilities. |
8.5 Employee retention rates and talent acquisition. |
9 Grenada Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Grenada Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Grenada Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Grenada Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Grenada Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Grenada Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Grenada Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |